(3,4-Dehydro-Pro2·3)-Bradykinin incorporates a dehydroproline modification at positions 2 and 3, enhancing structural rigidity and resistance to proteolysis. The altered residues affect the peptide's secondary structure and receptor-binding efficiency. Researchers use this variant to investigate the role of bradykinin in inflammatory responses and vasodilation. The dehydroproline modification provides insights into conformational changes during receptor activation.
CAT No: B09031
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More